Hempshire Group Past Earnings Performance
Past criteria checks 0/6
Hempshire Group's earnings have been declining at an average annual rate of -32.7%, while the Pharmaceuticals industry saw earnings growing at 32.1% annually. Revenues have been declining at an average rate of 32.3% per year.
Key information
-32.7%
Earnings growth rate
-8.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | -32.3% |
| Return on equity | n/a |
| Net Margin | -1,265.1% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Hempshire Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 0 | -2 | 2 | 0 |
| 30 Jun 23 | 0 | -3 | 2 | 0 |
| 31 Mar 23 | 0 | -6 | 2 | 0 |
| 31 Dec 22 | 0 | -7 | 2 | 0 |
| 30 Sep 22 | 0 | -7 | 2 | 0 |
| 30 Jun 22 | 0 | -6 | 2 | 0 |
| 31 Mar 22 | 0 | -3 | 2 | 0 |
| 31 Dec 21 | 0 | -2 | 2 | 0 |
| 31 Dec 20 | 0 | 0 | 0 | 0 |
Quality Earnings: HMPG is currently unprofitable.
Growing Profit Margin: HMPG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if HMPG's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare HMPG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HMPG is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (32.7%).
Return on Equity
High ROE: HMPG's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.